Mayne Pharma signs 20-year agreement for novel oral contraceptive in the US
ADELAIDE: Mayne Pharma has entered into an exclusive license and supply agreement with Mithra Pharmaceuticals to commercialise E4/DRSP, a combined oral contraceptive, in the United States. The product is expected…